|
π’
|
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.
9 auth.
E. Small,
P. Schellhammer,
C. Higano,
C. Redfern,
J. Nemunaitis,
F. Valone,
...
S. Verjee,
L. Jones,
R. Hershberg
|
10 |
2006 |
10
π’
|
|
π
|
Intestinal epithelial cells secrete exosome-like vesicles.
7 auth.
G. Niel,
G. Raposo,
C. Candalh,
Muriel Boussac,
R. Hershberg,
N. CerfβBensussan,
...
M. Heyman
|
9 |
2001 |
9
π
|
|
π’
|
Bacterial flagellin is a dominant antigen in Crohn disease.
8 auth.
M. Lodes,
Y. Cong,
C. Elson,
R. Mohamath,
C. Landers,
S. Targan,
...
M. Fort,
R. Hershberg
|
9 |
2004 |
9
π’
|
|
π’
|
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.
9 auth.
S. Targan,
C. Landers,
Huiying Yang,
M. Lodes,
Y. Cong,
K. Papadakis,
...
E. Vasiliauskas,
C. Elson,
R. Hershberg
|
8 |
2005 |
8
π’
|
|
π
|
Hypoxia-Inducible Factor 1βDependent Induction of Intestinal Trefoil Factor Protects Barrier Function during Hypoxia
8 auth.
G. Furuta,
J. Turner,
C. Taylor,
R. Hershberg,
Katrina M. Comerford,
S. Narravula,
...
D. Podolsky,
S. Colgan
|
8 |
2001 |
8
π
|
|
π’
|
Bacterial flagellin is a dominant antigen in Crohn disease
8 auth.
M. Lodes,
Y. Cong,
C. Elson,
R. Mohamath,
C. Landers,
S. Targan,
...
M. Fort,
R. Hershberg
|
8 |
2004 |
8
π’
|
|
π¦
|
Antigen processing and presentation by intestinal epithelial cells - polarity and complexity.
R. Hershberg,
L. Mayer
|
8 |
2000 |
8
π¦
|
|
π
|
Serum Immune Responses Predict Rapid Disease Progression among Children with Crohn's Disease: Immune Responses Predict Disease Progression
25 auth.
M. Dubinsky,
Ying-Chao Lin,
Debra Dutridge,
Y. Picornell,
C. Landers,
Sharmayne Farrior,
I. Wrobel,
A. Quiros,
E. Vasiliauskas,
B. Grill,
D. Israel,
R. Bahar,
D. Christie,
G. Wahbeh,
G. Silber,
...
Saied Dallazadeh,
P. Shah,
Danny Thomas,
D. Kelts,
R. Hershberg,
C. Elson,
S. Targan,
K. Taylor,
J. Rotter,
Huiying Yang
|
8 |
2006 |
8
π
|
|
π
|
Taking toll: lipid A mimetics as adjuvants and immunomodulators.
7 auth.
D. Persing,
R. Coler,
M. Lacy,
David A. Johnson,
J. Baldridge,
R. Hershberg,
...
S. Reed
|
7 |
2002 |
7
π
|
|
π¦
|
Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing.
9 auth.
R. Hershberg,
Paul E. Framson,
Diane H. Cho,
Lawrence Y. Lee,
Susan Kovats,
Jill Beitz,
...
Janice S. Blum,
G. T. Nepom,
G. T. Nepom
|
7 |
1997 |
7
π¦
|
|
π’
|
A Synthetic TLR4 Antagonist Has Anti-Inflammatory Effects in Two Murine Models of Inflammatory Bowel Disease 1
13 auth.
M. Fort,
Afsaneh Mozaffarian,
A. G. StoΜver,
J. S. Correia,
David A. Johnson,
R. Crane,
R. Ulevitch,
D. Persing,
H. Bielefeldt-Ohmann,
P. Probst,
...
E. Jeffery,
S. Fling,
R. Hershberg
|
7 |
2005 |
7
π’
|
|
π¦
|
Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells.
7 auth.
R. Hershberg,
Diane H. Cho,
Adel Youakim,
M. Bradley,
Janet S Lee,
Paul E. Framson,
...
G. T. Nepom
|
7 |
1998 |
7
π¦
|
